3:57 PM
 | 
May 16, 2018
 |  BC Extra  |  Company News

Management tracks: Novartis, Aileron

Editor's Note: This article was updated on May 17, 2018 at 9:55 AM PDT

Novartis AG (NYSE:NVS; SIX:NOVN) said General Counsel Felix Ehrat will retire, effective June 1, in light of Novartis' payments to a consultancy owned by Michael Cohen. "As a co-signatory with our former CEO, I take personal responsibility to bring the public debate on this matter to an end," he said in a statement. He will be succeeded by Chief Ethics, Risk and Compliance Officer Shannon Thyme Klinger (see BioCentury Extra, May 9).

Stapled peptide company Aileron Therapeutics Inc. (NASDAQ:ALRN) said President and CEO Joseph Yanchik has resigned. He is succeeded by John Longenecker as interim CEO. Longenecker was president and CEO at HemaQuest Pharmaceuticals Inc., which became Viracta Therapeutics Inc. (San Diego, Calif.).

Astellas Pharma Inc. (Tokyo:4503) promoted Bernhardt Zeiher to CMO. He will continue to serve as president of development.

Cancer company Five Prime Therapeutics Inc. (NASDAQ:FPRX) said Bryan Irving will transition to EVP and CSO from VP of research.

Anti-aging company Unity Biotechnology Inc. (NASDAQ:UBX) hired Camille Landis as SVP of corporate development. She was CBO at Eidos Therapeutics Inc. (San Francisco, Calif.).

Immuno-oncology company Sensei Biotherapeutics Inc. (Gaithersburg, Md.), formerly Panacea Pharmaceuticals Inc., hired John Celebi as president and CEO. He was COO at X4 Pharmaceuticals Inc. (Cambridge, Mass.)

Biosimilar company Adello Biologics LLC (Piscataway, N.J.) said CEO Peter Moesta will step down. He is succeeded by Chintu Patel, who was co-CEO, co-chairman and co-founder of Amneal Pharmaceuticals Inc. (NYSE:AMRX).

Ophthalmology company Horama S.A. (Paris, France) appointed Russell Greig as chairman of the board. Greig is chairman of Ablynx N.V. (Euronext:ABLX; NASDAQ:ABLX), AM-Pharma B.V. (Bunnik, the Netherlands), Mint Solutions (Amsterdam, the Netherlands), eTheRNA Immunotherapies N.V. (Niel, Belgium) and Laboratoris Sanifit S.L. (Palma de Mallorca, Spain).

Roivant Sciences GmbH (Basel, Switzerland) hired Salomon Azoulay as CMO and Adele Gulfo as chief of commercial development. Azoulay was SVP and CMO for Pfizer Essential Health at Pfizer Inc. (NYSE:PFE). Gulfo was EVP, chief strategy officer and head of global commercial development at Mylan N.V. (NASDAQ:MYL).

Autoimmune company ImmusanT Inc. (Cambridge, Mass.) hired Ken Truitt as CMO. He was SVP of internal medicine therapeutic areas at Daiichi Sankyo Co. Ltd. (Tokyo:4568).

Immuno-oncology company Quentis Therapeutics Inc. (New York, N.Y.) hired Jeanne Magram as CSO. She was CSO at Northern Biologics Inc. (Toronto, Ontario).

Dermatology company Trevi Therapeutics Inc. (New Haven, Conn.) hired Christopher Seiter as CFO. He was CFO at Millendo Therapeutics Inc. (Ann Arbor, Mich.).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD